Formulation and Evaluation of Pharmaceutical Microbeads

Abstract

Microbeads are tiny, spherical polymeric particles that are used extensively in the biomedical, cosmetic, and pharmaceutical industries. They range in size from 1 µm to 1000 µm.  They are an effective carrier system for targeted and regulated drug delivery because of their special physicochemical characteristics, which include high surface area, biocompatibility, and the capacity to encapsulate both hydrophilic and hydrophobic medications.  To obtain the necessary drug release profiles and stability, a variety of natural and synthetic polymers, including as alginate, chitosan, gelatine, pectin, and xanthan gum, are used in the manufacturing of microbeads. The type of medication, polymer, and intended release properties all influence the method choice.  To guarantee optimal performance, the prepared microbeads are assessed for swelling index, drug entrapment efficiency, surface morphology (using SEM), particle size distribution, and in-vitro drug release behaviour. With benefits including longer therapeutic action, fewer doses, and better patient compliance, microbeads have found use in parenteral, topical, and oral drug delivery systems.  The formulation strategies, characterisation methods, medicinal uses, and most current developments in microbeads technology are all covered in detail in this chapter.  Additionally, it highlights how synthetic microbeads affect the environment and the necessity of sustainable materials and regulatory oversight to guarantee both environmental safety and therapeutic efficacy.